Jazz Pharmaceuticals plc — Director's Dealing 2019

Feb 5, 2019

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-12-31

Reporting Person: Winningham Rick E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-24	Ordinary Shares	G	1720	$0.00	Disposed	3230	Direct

Footnotes

F1: Represents ordinary shares that the Reporting Person donated as a gift to the Fidelity Investment Charitable Gift Fund, a donor advised fund.